MetaCap

SOPHiA GENETICS SA Financial Ratios

NASDAQ: SOPHTechnologyEDP ServicesUSD

7.41+0.11 (+1.51%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

SOPHiA GENETICS SA ratio analysis

SOPHiA GENETICS SA earned a net margin of -102.2% in FY 2025, down from -95.9% a year earlier. Gross margin was 67.4% compared with a median of 66.6% over the prior 6 years. Return on equity reached -167.6%, meaning SOPHiA GENETICS SA generated -1.68 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 1.01 versus 0.14 the year before, and the current ratio was 1.96. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

SOPHiA GENETICS SA financial ratios (annual)

SOPHiA GENETICS SA annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Price / sales4.083.304.892.7819.28——
Price / book6.692.232.010.662.83——
Gross margin67.4%67.4%68.8%65.7%62.4%62.3%70.3%
Operating margin-91.8%-102.1%-120.0%-184.7%-176.7%-131.6%—
Net margin-102.2%-95.9%-126.6%-183.9%-182.1%-138.5%-133.2%
Free cash flow margin-47.2%-68.7%-87.7%-156.0%-149.9%-113.3%-130.3%
Return on equity (ROE)-167.6%-64.8%-52.2%-43.7%-26.8%-39.1%-151.8%
Return on assets (ROA)-48.5%-40.2%-38.3%-35.9%-23.0%-29.8%—
Debt / equity1.010.140.00——0.03—
Current ratio1.963.714.167.329.895.08—
Revenue growth18.6%4.5%31.1%17.6%42.4%12.0%—

Related